Australian University Rankings Guide

Endocrine Metabolic and Immune Disorders: Drug Targets (ERA Journal)

Endocrine Metabolic and Immune Disorders: Drug Targets is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Endocrine Metabolic and Immune Disorders: Drug Targets issns are issn1: 1871-5303 issn2: 2212-3873.

The fields covered by Endocrine Metabolic and Immune Disorders: Drug Targets as part of the evaluation of Australian university research excellence are:

Immunology Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Immunology field include:

- Alergia Astma Immunologia
- Clinical Reviews in Allergy and Immunology
- Current Allergy and Clinical Immunology
- Current Trends in Immunology
- Developmental and Comparative Immunology
- European Journal of Immunology
- Infectious diseases and therapy
- Journal of Asthma and Allergy
- Journal of Dermatological Case Reports
- Journal of Immunoassay and Immunochemistry
- Journal of Neuroimmune Pharmacology
- Journal of Neuroimmunology
- Nature Immunology
- OncoImmunology
- Scandinavian Journal of Immunology


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4